1-2 of 2
Alexis Mark
Close
Save search
Sort by
Journal Articles

An Ongoing Pilot Study of Targeted Radioimmunotherapy (131-I Apamistamab) Conditioning Prior to CD19-Targeted CAR T-Cell Therapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Free
Mark B. Geyer, Briana Cadzin, Kinga Hosszu, Brigitte Senechal, Jennifer A. Spross, Alexis Mark, Avinash Desai, Elizabeth R. Cathcart, M. Lia Palomba, Neeta Pandit-Taskar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10341–10342.
https://doi.org/10.1182/blood-2022-167962
Published: 2022
Journal Articles

Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) after Idelalisib Therapy Discontinuation

Free
Jacqueline C. Barrientos, MD, Manmeen Kaur, MD, Alexis Mark, Jaewon Chung, Nancy Driscoll, PA-C, Alison Bender, PA-C, Kanti R. Rai, MD
Journal: Blood
Blood (2015) 126 (23): 4155.
https://doi.org/10.1182/blood.V126.23.4155.4155
Published: 2015